 "Pfizer to acquire oncology specialist Medivation for $ 14 bn")
AstraZeneca AB, Sweden, has sold its antacid brand Neksium to Pfizer Ltd, which also owns Gelusil brand, for Rs 75 crore. The transaction is subject to completion of requisite clearances.
Launched in India in 2006, Neksium is one the leading brands in the anti-peptic ulcerant space. Neksium, with the active ingredient esomeprazole belongs to a class of pharmaceutical preparations called proton pump inhibitors (PPI), which are used effectively for reducing the acid secretion in the stomach. It is widely prescribed for the treatment of conditions across the acid peptic disorders (APD) spectrum.
“The Neksium acquisition is aligned with our stated ambition of
